netFormulary Northern Lincolnshire NHS
Formulary  
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
02.09  Expand sub section  Antiplatelet drugs
Aspirin
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Soluble Tablets

 
   
Clopidogrel
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Tablet

 
Link  MHRA Clopidogrel: risk of acquired haemophilia
Link  NICE TA20 Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events
   
Dipyridamole MR
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Capsule

Amber Traffic Light Dipyridamole Suspension

Red Traffic Light Dipyridamole injection

 
Link  NICE TA20 Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events
   
Prasugrel (Efient)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
 
Link  MHRA Prasugrel (Efient): increased risk of bleeding
Link  NICE TA 182 Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention
Link  NICE TA317 (replaces TA182): Acute coronary syndrome - prasugrel
   
Dipyridamole and Aspirin
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber

Modified Release Capsule

 
Link  Asasantin Retard Discontinues
   
Ticagrelor (Brilique)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
 
Link  NICE TA236: Ticagrelor for the treatment of acute coronary syndromes
Link  NICE TA420: Ticagrelor for preventing atherothrombotic events after myocardial infarction
   
Eptifibatide (Integrilin)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

INJECTION

 
   
Tirofiban (Aggrastat)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

INJECTION

 
   
Abciximab
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Injection

 
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Green -Medicines suitable for routine use within primary care and Secondary care Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies  

Amber

Amber- Medicines suitable to be prescribed in primary care after specialist /Consultant recommendation or initiation. A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust Medicines and Therapeutic Committee and approved by the Area Prescribing Committee.   

Red

Red-Hospital initiation and continuation only  

Amber Shared Care Protocol

AMBER SHARE CARE PROTOCOL- Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised  

Blue

To be supplied from the appropriate commissioned provider.   

Green 2

GREEN 2- to be prescribed by primary care only   

Grey

GREY- NON FORMULARY (As agreed by Area Prescribing Committee)  

netFormulary